| Nov 13 |
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
|
| Nov 10 |
ClearPoint Neuro: Near-Term Volatility Is No Concern
|
| Nov 10 |
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
|
| Nov 8 |
ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
ClearPoint Neuro GAAP EPS of -$0.18 misses by $0.01, revenue of $8.12M beats by $0.34M
|
| Nov 7 |
ClearPoint Neuro Reports Third Quarter 2024 Results
|
| Nov 6 |
ClearPoint Neuro Q3 2024 Earnings Preview
|
| Nov 6 |
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213%
|
| Oct 31 |
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
|
| Oct 31 |
ClearPoint Neuro: Investors Enamored With Its Growth Prospects
|
